Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition

August 14, 2025
Medical Communications, Research and Development European Alliance of Associations for Rheumatology, European Medicines Agency, IgG4-related disease, Rheumatology, Sanofi

The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) inhibitor, rilzabrutinib, for the treatment …

News
Patients image

PhotoPharmics expands Parkinson’s Trial into further US states

August 14, 2025
Research and Development Neurology, PhotoPharmics, clinical trial, neurodegenerative disorders

US-based PhotoPharmics, has expanded enrollment in its Light for PD clinical trial beyond its original 300 participants, opening new sites …

News

Medidata appoints Lisa Moneymaker as chief strategy officer

August 13, 2025
Clinical Trial Services, Research and Development Corporate, Medidata, chief strategy officer

Medidata has appointed Lisa Moneymaker as chief strategy officer to support the company’s long-term growth in the life sciences technology …

Appointment

Sandoz signs renewable energy deal to supply 90% of European operations

August 13, 2025
Mergers and Acquisitions Corporate, Elawan Energy, Sandoz, decarbonisation, renewable energy

Sandoz has entered into a ten-year virtual Power Purchase Agreement with Elawan Energy for the development of new solar projects …

News

CuraCell granted approval for trial of new therapy for metastatic cancers

August 13, 2025
Research and Development CuraCell, Immunology, clinical trial, immunotherapy, metastic cancer

Swedish immunotherapy company, CuraCell, has received approval from the Paul-Ehrlich-Institut in Germany to begin a phase 1/2a clinical trial of …

News
eye1

Eyestem secures $10m to advance cell therapy for advanced eye disease

August 13, 2025
Medical Communications, Research and Development Eyestem, Opthalmology, cell therapy, dry age-related macular degeneration, geographic atrophy

Indian cell therapy company, Eyestem Research, has raised $10m in a funding round to support development of its investigational retinal …

News

Atelerix appoints new chair and non-executive director to drive global expansion

August 13, 2025
Biotech/start-up, Sales and Marketing Atelerix, Corporate, non-executive director

UK-based biotech company, Atelerix, has appointed Sunil Shah as chair of the board and Catherine Elton as non-executive director as …

Appointment
handshake-1910702_960_720

Sartorius Stedim Biotech partners with Nanotein Technologies to develop cell therapy manufacturing

August 12, 2025
Mergers and Acquisitions Corporate, Nanotein Technologies, Sartorius Stedim Biotech, cell therapy, gene therapy

Sartorius Stedim Biotech has partnered with Nanotein Technologies to expand access to immune cell activation reagents for cell therapy manufacturing. …

News

Enzymatica appoints Sana Alajmovic as new CEO

August 12, 2025
Research and Development Corporate, Enzymatica, Infections and infestations

The board of directors of Enzymatica has appointed Sana Alajmovic as chief executive officer, succeeding Claus Egstrand. Egstrand will step …

Appointment
bonecells

OS Therapies advances regulatory pathway for bone cancer therapy

August 11, 2025
Medical Communications, Research and Development European Medicines Agency’, Medicines and Healthcare products Regulatory Agency, OS Therapies, Oncology, Orthopaedics, US Food and Drug Administration’, bone cancer, osteosarcoma

OS Therapies has announced significant progress in its regulatory strategy for OST-HER2, its lead immunotherapy candidate for preventing or delaying …

News

Sanner appoints new CEO to drive CDMO strategy

August 11, 2025
Contract Manufacturing, Manufacturing and Production CEO, Corporate, Sanner, contract development and manufacturing organisation

German packaging solutions company, Sanner, has announced a significant leadership change as it advances its transformation into a contract development …

Appointment
640px-eye_iris

NICE recommends treatment for rare genetic eye disorder

August 11, 2025
Medical Communications Chiesi, Leber Hereditary Optic Neuropathy, NHS England, National Institute for Health and Care Excellence, Opthalmology, Rare Diseases

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Cheisi’s idebenone (Raxone) within its …

News

ARTBIO expands board and establishes technical advisory board

August 11, 2025
Medical Communications, Research and Development ARTBIO, Corporate, Oncology, advisory board, radiopharmaceuticals

ARTBIO, a radiopharma company developing radioligand therapies (RLTs), has appointed four new members to its board of directors and formed …

Appointment
pills-384846_960_720

Lilly reports positive results from trial of obesity candidate

August 8, 2025
Medical Communications, Research and Development Eli Lilly and Company, Obesity, cardiovascular risk, high blood pressure, obesity

Eli Lilly and Company (Lilly) has announced topline results from its phase 3 ATTAIN-1 trial, showing that orforglipron – a …

News
az_vaccine

Rollout of world-first gonorrhoea vaccine programme begins under NHS

August 8, 2025
Medical Communications 10 Year Health Plan, Genito-Urinary system, Infections and infestations, NHS, gonorrhoea, sexual health, sexually transmitted infections, vaccination

From 4 August, sexual health clinics in England have been able to offer a free vaccine – the 4CMenB vaccine …

News

Horus Pharma expands distribution in North Africa and the Middle East

August 8, 2025
Mergers and Acquisitions, Research and Development Corporate, Horus Pharma, Opthalmology, distribution agreement

Ophthalmology company, Horus Pharma, based in Nice, France, has extended its global presence through new distribution agreements across eight countries …

News

Aragen appoints Aniel Khubchandani as CEO of development and manufacturing solutions division

August 8, 2025
Manufacturing Services, Manufacturing and Production Aragen Life Sciences, CEO, Corporate, development and manufacturing solutions, manufacturing services

Aragen Life Sciences, based in Hyderabad, India, has appointed Aniel Khubchandani as CEO of its development and manufacturing solutions (DMS) …

Appointment
drug-trials

Faron reports increased remission rate in trial for myelodysplastic syndrome candidate

August 7, 2025
Medical Communications, Research and Development Faron Pharmaceuticals, Oncology, US Food and Drug Administration, acute myeloid leukemia, myelodysplastic syndrome

Faron Pharmaceuticals has reported a rise in complete remission (CR) rates among patients with frontline high-risk myelodysplastic syndrome (HR-MDS) in …

News
hospital

Sanome’s AI tool gains certification for early detection of hospital infections

August 7, 2025
Business Services, Research and Development AI, Devices, Infections and infestations, Medicines and Healthcare products Regulatory Agency, NHS, Sanome, hospital-acquired infections

Sanome’s MEMORI, an artificial intelligence (AI) medical device that can predict hospital-acquired infections up to 72 hours before they present, …

News
computer_doctor

Cognizant launches tool to support secure AI integration in healthcare platforms

August 7, 2025
Business Services, Technical Consultancy Cognizant, Devices, healthcare software

US tech solutions company, Cognizant, has launched TriZetto AI Gateway, a new tool designed to embed generative AI functions across …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026